Search - tctmd.com

Displaying 1 - 20 of 36

Sort: Relevancy | Date

News Conference News TCT 2016

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Michael O'Riordan

October 30, 2016

News Industry News

Micell Technologies Highlights Data From Published Propensity Analysis of MiStent SES® and Market Standard Xience V® Coronary Stent

February 24, 2016

News Features

Increased Early Risk of Stent Thrombosis With the Absorb Bioresorbable Scaffold

Michael O'Riordan

January 06, 2016

News Daily News

Residual Dissection After DCB Treatment for De Novo CAD Generally Resolves

Caitlin E. Cox

November 26, 2015

News Industry News

Plaque Modification With Scoring Balloon Improves Angiographic Outcomes In Patients Treated With A Drug-Coated Balloon For Drug-Eluting Stent Restenosis

October 14, 2015

News Conference News TCT 2015

ISAR-DESIRE 4: Scoring Balloon Predilation Effective at 1 Year in Patients With DES Restenosis

October 14, 2015

News Industry News

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

May 19, 2015

Presentation TCT 2014

Are There Meaningful Differences in Vascular Responses Between the Different Classes of Metallic Stent Technologies?

Presenter: Robert A. Byrne, Didier Carrié, Giuseppe De Luca, Francesco Prati

September 15, 2014

Presentation TCT 2014

FOCUS np: Clinical and Angiographic Results with a Nanoparticle-Based Siroliumus-Eluting Stent and Balloon

Presenter: Robert A. Byrne, Didier Carrié, Giuseppe De Luca, Upendra Kaul

September 15, 2014

Presentation TCT 2014

BioFreedom: From Pilot Results to the Leaders-Free Trial

Presenter: Robert A. Byrne, Didier Carrié, Giuseppe De Luca, Philip M. Urban

September 15, 2014

Presentation TCT 2014

Amphillic Sirolimus-Eluting Cre8 Technology - New Studies and Future Directions

Presenter: Robert A. Byrne, Didier Carrié, Giuseppe De Luca

September 15, 2014

Presentation TCT 2014

The Drug-Filled Stent: From Concept to Clinical Development

Presenter: Robert A. Byrne, Didier Carrié, Giuseppe De Luca, Martin T. Rothman

September 15, 2014

Presentation TCT 2014

Pro Bioabsorbable Polymer-Based Metallic DES!

Presenter: Robert A. Byrne

September 15, 2014

Presentation TCT 2014

Case Study: DES in a High Bleeding Risk Patient with Complex Coronary Artery Disease

Presenter: Philip M. Urban, Marco Valgimigli, Christian M. Spaulding, Robert A. Byrne

September 14, 2014

Presentation TCT 2014

Approach to In-Stent Restenosis in 2014: DCB or DES?

Presenter: Run-Lin Gao, Jochen Wöhrle, Bruno Scheller, Robert A. Byrne

September 13, 2014

Presentation TCT 2014

DCB Plus Provisional Scaffold (BRS): Technique and Clinical Results

Presenter: Robert A. Byrne, Bruno Scheller, Francesco Liistro, Azeem Latib

September 13, 2014

Presentation TCT 2014

DCB Plus Adjunctive Stenting: Technique and Clinical Results

Presenter: Robert A. Byrne, Bruno Scheller, Francesco Liistro, Jochen Wöhrle

September 13, 2014

Presentation TCT 2014

DCB Only Followed by Provisional Stenting: Insights from BASKET-SMALL 2 Trial

Presenter: Robert A. Byrne, Bruno Scheller, Francesco Liistro, Raban Jeger

September 13, 2014

Presentation TCT 2014

Technique Strategy Selection: A Critical Review of International Consensus Group Position Papers

Presenter: Robert A. Byrne, Bruno Scheller, Francesco Liistro, Sahil A. Parikh

September 13, 2014

Presentation TCT 2014

DCB ONLY and Vascular Restoration: Insights from Intracoronary OCT Human Studies

Presenter: Robert A. Byrne, Bruno Scheller, Francesco Liistro, Tudor C Poerner

September 13, 2014

Advertisement

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Micell Technologies Highlights Data From Published Propensity Analysis of MiStent SES® and Market Standard Xience V® Coronary Stent

Increased Early Risk of Stent Thrombosis With the Absorb Bioresorbable Scaffold

Residual Dissection After DCB Treatment for De Novo CAD Generally Resolves

Plaque Modification With Scoring Balloon Improves Angiographic Outcomes In Patients Treated With A Drug-Coated Balloon For Drug-Eluting Stent Restenosis

ISAR-DESIRE 4: Scoring Balloon Predilation Effective at 1 Year in Patients With DES Restenosis

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

Are There Meaningful Differences in Vascular Responses Between the Different Classes of Metallic Stent Technologies?

FOCUS np: Clinical and Angiographic Results with a Nanoparticle-Based Siroliumus-Eluting Stent and Balloon

BioFreedom: From Pilot Results to the Leaders-Free Trial

Amphillic Sirolimus-Eluting Cre8 Technology - New Studies and Future Directions

The Drug-Filled Stent: From Concept to Clinical Development

Pro Bioabsorbable Polymer-Based Metallic DES!

Case Study: DES in a High Bleeding Risk Patient with Complex Coronary Artery Disease

Approach to In-Stent Restenosis in 2014: DCB or DES?

DCB Plus Provisional Scaffold (BRS): Technique and Clinical Results

DCB Plus Adjunctive Stenting: Technique and Clinical Results

DCB Only Followed by Provisional Stenting: Insights from BASKET-SMALL 2 Trial

Technique Strategy Selection: A Critical Review of International Consensus Group Position Papers

DCB ONLY and Vascular Restoration: Insights from Intracoronary OCT Human Studies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content